Kintor Pharmaceutical Limited announced on 23 March 2026 that its board meeting—initially set for 26 March 2026—has been rescheduled to 30 March 2026.

The meeting’s agenda remains unchanged and will focus on reviewing and approving the company’s annual results for the financial year ended 31 December 2025, together with the related results announcement.

According to the filing, the postponement was prompted by directors’ scheduling considerations.

The board is chaired by Dr. Youzhi Tong, who also serves as Executive Director and Chief Executive Officer. Other directors include Executive Director Dr. Xiang Ni; Non-executive Directors Mr. Yunfei Chen and Ms. Geqi Wei; and Independent Non-executive Directors Dr. Michael Min Xu, Mr. Wallace Wai Yim Yeung and Prof. Liang Tong.